Example: Heart Attack

Search clinical trials for: Fibrinolysin

Total 44 results

NCT00347646

Terminated

A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)

Conditions: Vitreoretinal Traction Syndrome
NCT00348439

Terminated

Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment

Conditions: Vitreoretinal Traction Syndrome
NCT01014975

Completed

A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients

Conditions: Acute Ischemic Stroke
NCT01222117

Completed

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Conditions: Acute Peripheral Arterial Occlusion
NCT00640289

Completed

Clinical Trial of Factor XIII (FXIII) Concentrate

Conditions: Hemophilia; Factor XIII Deficiency
NCT00418483

Completed

A Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft Occlusion

Conditions: Arterial Occlusive Diseases
NCT01478516

Unknown status

Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy

Conditions: Macular Edema
NCT04218890

Not yet recruiting

TF, TFPI and Plasmin as Novel Bio-markers in Early Diagnosis of Lupus Nephritis

Conditions: Lupus Nephritis
NCT00885742

Completed

A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

Conditions: Factor XIII Deficiency
NCT00883090

Completed

A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency

Conditions: Factor XIII Deficiency
NCT04021173

Not yet recruiting

A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Conditions: Acquired Thrombotic Thrombocytopenic Purpura
NCT00945906

Completed

An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

Conditions: Factor XIII Deficiency
NCT03078257

Unknown status

Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients

Conditions: Coronary Artery Disease
NCT02681809

Completed

A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR

Conditions: Diabetic Retinopathy; Posterior Vitreous Detachment; Disease Progression
NCT04404790

Suspended

Antiplatelet Thrombolysin (Anfibatide) Phase 1 Clinical Trial in Healthy Volunteers

Conditions: Antiplatelet Drug
NCT01159665

Completed

The Purpose of This Study is to Evaluate the Pharmacokinetic Properties of Intravitreal Ocriplasmin Prior to Planned Primary Pars Plana Vitrectomy (PPV)

Conditions: Vitrectomy
NCT00435539

Completed

A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)

Conditions: Vitreomacular Traction
NCT00412958

Completed

A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)

Conditions: Vitrectomy
NCT00123305

Completed

Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke

Conditions: Stroke, Acute
NCT00123292

Terminated

Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion

Conditions: Arterial Occlusive Diseases
NCT03741023

Enrolling by invitation

Disorders of the Acute Phase Response Following Trauma and Invasive Surgery

Conditions: Acute Phase Response
NCT02495012

Unknown status

Anfibatide Treatment in STEMI Patients

Conditions: ST Segment Elevation Myocardial Infarction
NCT01585259

Completed

Anfibatide Phase Ib-IIa Clinical Trial

Conditions: Non-ST Segment Elevation Myocardial Infarction
NCT02187120

Recruiting

Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study)

Conditions: Wounds and Injuries; Acute Coagulopathy
NCT02257580

Active, not recruiting

The Effect of Intravenous EACA on Blood Loss and Transfusion Requirements After Bilateral VRO

Conditions: E-Aminocaproic Acid; Bilateral Varus Rotational Osteotomy